# 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

> **NCT06937112** · — · RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Lung Cancers
- Pancreatic Cancer
- Neuroendocrine Tumors
- Thyroid Cancer

## Interventions

- **OTHER:** PET-CT examination

## Key facts

- **NCT ID:** NCT06937112
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937112, "18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06937112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*